MANDEEP BAJAJ to Glucagon-Like Peptide 1
This is a "connection" page, showing publications MANDEEP BAJAJ has written about Glucagon-Like Peptide 1.
Connection Strength
0.988
-
Direct actions of GLP-1 analogues on AMP-activated protein kinase activity are distinct from cyclic AMP accumulation. J Hepatol. 2013 Mar; 58(3):634-5.
Score: 0.403
-
Myocardial protection against ischemia-reperfusion injury by GLP-1: molecular mechanisms. Metab Syndr Relat Disord. 2012 Dec; 10(6):387-90.
Score: 0.399
-
Potential of incretin-based therapies for non-alcoholic fatty liver disease. J Diabetes Complications. 2013 Jul-Aug; 27(4):401-6.
Score: 0.102
-
Compounded GLP-1 and Dual GIP/GLP-1 Receptor Agonists: A Statement from the American Diabetes Association. Diabetes Care. 2025 Feb 01; 48(2):177-181.
Score: 0.059
-
Phosphodiesterase III inhibition increases cAMP levels and augments the infarct size limiting effect of a DPP-4 inhibitor in mice with type-2 diabetes mellitus. Cardiovasc Drugs Ther. 2012 Dec; 26(6):445-56.
Score: 0.025